US Firm Aims For 2 Billion COVID Vaccine Doses With Expanded India Deal

US drug developer Novavax said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually under an agreement with Serum Institute of India, sending…

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like